Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dali Yin

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Talanta|July 3, 2021
Developing fluoromodule-based probes for in vivo monitoring the bacterial infections and antibiotic responsesXiang Wang, Qinghua Wang, Qingyang Zhang, et al.
Journal of Materials Chemistry. B|October 18, 2022
Bio-orthogonally activated tetraphenylene-tetrazine aggregation-induced emission fluorogenic probesYu Teng, Rongrong Zhang, Bingbing Yang, et al.
Frontiers in Pharmacology|October 26, 2017
Prediction of a Therapeutic Dose for Buagafuran, a Potent Anxiolytic Agent by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Starting from Pharmacokinetics in Rats and HumanFen Yang, Baolian Wang, Zhihao Liu, et al.
European Journal of Medicinal Chemistry|July 30, 2014
Discovery of oxazole and triazole derivatives as potent and selective S1P(1) agonists through pharmacophore-guided designYulin Tian, Jing Jin, Xiaojian Wang, et al.
European Journal of Medicinal Chemistry|March 29, 2014
Design, synthesis and evaluation of novel diaryl urea derivatives as potential antitumor agentsChenshu Lu, Ke Tang, Yan Li, et al.
Biochemical Pharmacology|May 1, 2014
Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitisJing Jin, Jinping Hu, Wanqi Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2009
Efficient gene therapy-based method for the delivery of therapeutics to primate cortexAdrian P Kells, Piotr Hadaczek, Dali Yin, et al.
Cancer Letters|June 7, 2002
The initial evaluation of non-peptidic small-molecule HDM2 inhibitors based on p53-HDM2 complex structureJianhua Zhao, Mijuan Wang, Jie Chen, et al.
Molecules (Basel, Switzerland)|February 5, 2013
Design, synthesis and hepatoprotective activity of analogs of the natural product goodyeroside AFeng Zhang, Bei Han, Peng Li, et al.
Bioorganic & Medicinal Chemistry Letters|April 7, 2020
S1P<sub>1</sub>-selective agonist prodrug IMMH002 is phosphorylated in rats to form an S-configured enantiomer: Synthesis, verification, and biological activity of the in vivo active metaboliteQiong Xiao, Minwan Hu, Si Chen, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Talanta|July 3, 2021
Developing fluoromodule-based probes for in vivo monitoring the bacterial infections and antibiotic responsesXiang Wang, Qinghua Wang, Qingyang Zhang, et al.
Journal of Materials Chemistry. B|October 18, 2022
Bio-orthogonally activated tetraphenylene-tetrazine aggregation-induced emission fluorogenic probesYu Teng, Rongrong Zhang, Bingbing Yang, et al.
Frontiers in Pharmacology|October 26, 2017
Prediction of a Therapeutic Dose for Buagafuran, a Potent Anxiolytic Agent by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Starting from Pharmacokinetics in Rats and HumanFen Yang, Baolian Wang, Zhihao Liu, et al.
European Journal of Medicinal Chemistry|July 30, 2014
Discovery of oxazole and triazole derivatives as potent and selective S1P(1) agonists through pharmacophore-guided designYulin Tian, Jing Jin, Xiaojian Wang, et al.
European Journal of Medicinal Chemistry|March 29, 2014
Design, synthesis and evaluation of novel diaryl urea derivatives as potential antitumor agentsChenshu Lu, Ke Tang, Yan Li, et al.
Biochemical Pharmacology|May 1, 2014
Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitisJing Jin, Jinping Hu, Wanqi Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2009
Efficient gene therapy-based method for the delivery of therapeutics to primate cortexAdrian P Kells, Piotr Hadaczek, Dali Yin, et al.
Cancer Letters|June 7, 2002
The initial evaluation of non-peptidic small-molecule HDM2 inhibitors based on p53-HDM2 complex structureJianhua Zhao, Mijuan Wang, Jie Chen, et al.
Molecules (Basel, Switzerland)|February 5, 2013
Design, synthesis and hepatoprotective activity of analogs of the natural product goodyeroside AFeng Zhang, Bei Han, Peng Li, et al.
Bioorganic & Medicinal Chemistry Letters|April 7, 2020
S1P<sub>1</sub>-selective agonist prodrug IMMH002 is phosphorylated in rats to form an S-configured enantiomer: Synthesis, verification, and biological activity of the in vivo active metaboliteQiong Xiao, Minwan Hu, Si Chen, et al.
Pageof 9